ACS Medicinal Chemistry Letters
Page 6 of 10
4. Liu, T.; Zhang, H.-T.; Liu, F.-Y.; Wu, Q.-Y.; Shen, X.; Yang, Q.
Structural and functional insight into human O-GlcNAcase. Nat.
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
Structural determinants of an insect β-N-Acetyl-D-hexosaminidase
specialized as a chitinolytic enzyme. J. Biol. Chem. 2011, 286, 4049-
Chem. Biol. 2017, 13, 610-612.
17. Glawar, A. F. G.; Martinez, R. F.; Ayers, B. J.; Hollas, M. A.;
Ngo, N.; Nakagawa, S.; Kato, A.; Butters, T. D.; Fleet, G. W. J.;
Jenkinson, S. F. Structural essentials for β-N-acetylhexosaminidase
inhibition by amides of prolines, pipecolic and azetidine carboxylic
acids. Org. Biomol. Chem. 2016, 14, 10371-10385.
18. Kong, H.; Chen, W.; Lu, H.; Yang, Q.; Dong, Y.; Wang, D.;
Zhang, J. Synthesis of NAG-thiazoline-derived inhibitors for β-N-
acetyl-D-hexosaminidases. Carbohydr. Res. 2015, 413, 135-144.
19. Hattie, M.; Cekic, N.; Debowski, A. W.; Vocadlo, D. J.; Stubbs, K.
A. Modifying the phenyl group of PUGNAc: reactivity tuning to
deliver selective inhibitors for N-acetyl-D-glucosaminidases. Org.
Biomol. Chem. 2016, 14, 3193-3197.
4
5
058.
. Liu, T.; Chen, L.; Ma, Q.; Shen, X.; Yang, Q. Structural insights
into chitinolytic enzymes and inhibition mechanisms of selective
inhibitors. Curr. Pharm. Design 2014, 20, 754-770.
6. Zhu, Y.; Shan, X.; Safarpour, F.; Erro Go, N.; Li, N.; Shan, A.;
Huang, M. C.; Deen, M.; Holicek, V.; Ashmus, R.; Madden, Z.;
Gorski, S.; Silverman, M. A.; Vocadlo, D. J. Pharmacological
inhibition of O-GlcNAcase enhances autophagy in brain through an
mTOR-Independent pathway. ACS Chem. Neurosci. 2018, 9, 1366-
1
7
379.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
. Ho, C. W.; Popat, S. D.; Liu, T. W.; Tsai, K. C.; Ho, M. J.; Chen,
W. H.; Yang, A. S.; Lin, C. H. Development of GlcNAc-inspired
iminocyclitiols as potent and selective N-acetyl-beta-hexosaminidase
inhibitors. Acs Chem. Biol. 2010, 5, 489-497.
8. Liu, T.; Yan, J.; Yang, Q. Comparative biochemistry of GH3,
GH20 and GH84 β-N-acetyl-D-hexosaminidases and recent progress
in selective inhibitor discovery. Curr. Drug Targets 2012, 13, 512-
20. Terinek, M.; Vasella, A. Synthesis of N-acetylglucosamine-
derived nagstatin analogues and their evaluation as glycosidase
inhibitors. Helv. Chim. Acta. 2005, 88, 10-22.
21. Ayers, B. J.; Glawar, A. F. G.; Martinez, R. F.; Ngo, N.; Liu, Z.;
Fleet, G. W. J.; Butters, T. D.; Nash, R. J.; Yu, C. Y.; Wormald, M. R.;
Nakagawa, S.; Adachi, I.; Kato, A.; Jenkinson, S. F. Nine of 16
stereoisomeric polyhydroxylated proline amides are potent β-N-
acetylhexosaminidase inhibitors. J. Org. Chem. 2014, 79, 3398-3409.
22. Tropak, M. B.; Blanchard, J. E.; Withers, S. G.; Brown, E. D.;
Mahuran, D. High-throughput screening for human lysosomal beta-N-
Acetyl hexosaminidase inhibitors acting as pharmacological
chaperones. Chem. Biol. 2007, 14, 153-64.
23. Guo, P.; Chen, Q.; Liu, T.; Xu, L.; Yang, Q.; Qian, X.
Development of unsymmetrical dyads as potent noncarbohydrate-
based inhibitors against human β-N-Acetyl-d-hexosaminidase. ACS
Med. Chem. Lett. 2013, 4, 527-531.
24. Liu, T.; Guo, P.; Zhou, Y.; Wang, J.; Chen, L.; Yang, H.; Qian, X.;
Yang, Q. A crystal structure-guided rational design switching non-
carbohydrate inhibitors' specificity between two β-GlcNAcase
homologs. Sci. Rep. 2014, 4, 6188-6183.
25. Shen, S.; Chen, W.; Dong, L.; Yang, Q.; Lu, H.; Zhang, J. Design
and synthesis of naphthalimide group-bearing thioglycosides as novel
β-N-acetylhexosaminidases inhibitors. J. Enzyme Inhib. Med. Chem.
2018, 33, 445-452.
5
9
25.
. Yuzwa, S. A.; Macauley, M. S.; Heinonen, J. E.; Shan, X.; Dennis,
R. J.; He, Y.; Whitworth, G. E.; Stubbs, K. A.; McEachern, E. J.;
Davies, G. J.; Vocadlo, D. J. A potent mechanism-inspired O-
GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat.
Chem. Biol. 2008, 4, 483-490.
1
0.Yuzwa, S. A.; Shan, X.; Macauley, M. S.; Clark, T.; Skorobogatko,
Y.; Vosseller, K.; Vocadlo, D. J. Increasing O-GlcNAc slows
neurodegeneration and stabilizes tau against aggregation. Nat. Chem.
Biol. 2012, 8, 393-399.
1
1. Yuzwa, S. A.; Vocadlo, D. J. O-GlcNAc and neurodegeneration:
biochemical mechanisms and potential roles in Alzheimer's disease
and beyond. Chem. Soc. Rev. 2014, 43, 6839-6858.
12. Ferrer, C. M.; Lynch, T. P.; Sodi, V. L.; Falcone, J. N.; Schwab, L.
P.; Peacock, D. L.; Vocadlo, D. J.; Seagroves, T. N.; Reginato, M. J.
O-GlcNAcylation regulates cancer metabolism and survival stress
signaling via regulation of the HIF-1 pathway. Mol. Cell 2014, 54,
8
20-831.
13. McClain, D. A.; Lubas, W. A.; Cooksey, R. C.; Hazel, M.; Parker,
G. J.; Love, D. C.; Hanover, J. A. Altered glycan-dependent signaling
induces insulin resistance and hyperleptinemia. Proc. Natl. Acad. Sci.
USA. 2002, 99, 10695-10699.
26. Chen, W.; Shen, S.; Dong, L.; Zhang, J.; Yang, Q. Selective
inhibition of β-N-acetylhexosaminidases by thioglycosyl-naph-
thalimide hybrid molecules. Bioorg. Med. Chem. 2018, 26, 394-400.
27. Paul, B.; Korytnyk, W. S-, N-, and O-glycosyl derivatives of 2-
acetamido-2-deoxy-D-glucose with hydrophobic aglycons as potential
14. Elsen, N. L.; Patel, S. B.; Ford, R. E.; Hall, D. L.; Hess, F.;
Kandula, H.; Kornienko, M.; Reid, J.; Selnick, H.; Shipman, J. M.;
Sharma, S.; Lumb, K. J.; Soisson, S. M.; Klein, D. J. Insights into
activity and inhibition from the crystal structure of human O-
GlcNAcase. Nat. Chem. Biol. 2017, 13, 613-615.
chemotherapeutic
agents
and
N-acetyl-β-D-glucosaminidase
inhibitors. Carbohydr. Res. 1984, 126, 27-43.
28. Krejzova, J.; Simon, P.; Kalachova, L.; Kulik, N.; Bojarova, P.;
Marhol, P.; Pelantova, H.; Cvacka, J.; Ettrich, R.; Slamova, K.; Kren,
V. Inhibition of GlcNAc-processing glycosidases by C-6-azido-NAG-
thiazoline and its derivatives. Molecules 2014, 19, 3471-3488.
29. Mark, B. L.; Mahuran, D. J.; Cherney, M. M.; Zhao, D.; Knapp, S.;
James, M. N. G. Crystal structure of human β-Hexosaminidase B:
Understanding the molecular basis of Sandhoff and Tay-Sachs disease.
J. Mol. Biol. 2003, 327, 1093-1109.
1
5. Li, B.; Li, H.; Lu, L.; Jiang, J. Structures of human O-GlcNAcase
and its complexes reveal a new substrate recognition mode. Nat.
Struct. Mol. Biol. 2017, 24, 362-369.
1
6. Roth, C.; Chan, S.; Offen, W. A.; Hemsworth, G. R.; Willems, L.
I.; King, D. T.; Varghese, V.; Britton, R.; Vocadlo, D. J.; Davies, G. J.
6
ACS Paragon Plus Environment